Applied Computational Technologies

Applied Computational Technologies (ACT) was a specialized software company that provided predictive modeling tools for the pharmaceutical and biotechnology industries. The company's primary focus was on developing in silico methods to predict the ADME (Absorption, Distribution, Metabolism, and Excretion) and toxicity properties of potential drug candidates. By providing early-stage insights into the pharmacokinetic profiles of compounds, ACT's technology enabled researchers to prioritize leads and reduce the likelihood of failure in clinical trials. Their software solutions were designed to integrate into the drug discovery workflow, offering high-throughput screening capabilities for chemical libraries. In 2003, the company was acquired by Accelrys, a leader in scientific software, to bolster its portfolio of predictive informatics. Following the acquisition, ACT's core technologies were incorporated into the Accelrys Discovery Studio platform, which continues to serve the global life sciences research community.